Chemical Formula: C23H36O6
Chemical Formula C23H36O6
Found 130 metabolite its formula value is C23H36O6
MG(PGJ2/0:0/0:0)
MG(PGJ2/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
MG(0:0/PGJ2/0:0)
MG(0:0/PGJ2/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).
[8]-Gingerdiol
[8]-gingerdiol is a member of the class of compounds known as fatty alcohol esters. Fatty alcohol esters are ester derivatives of a fatty alcohol. [8]-gingerdiol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). [8]-gingerdiol can be found in ginger, which makes [8]-gingerdiol a potential biomarker for the consumption of this food product.
(rel 5S,6R,8R,9R,10S,13S,16S)-6-acetoxy-9,13-epoxy-16-methoxy-labdan-15,16-olide
(3S,5S,8R,9R,10S,13S,16S)-3-acetoxy-9,13-epoxy-16-methoxylabdan-15,16-olide|negundoin D
Australifungin
A carbobicyclic compound that is 4a,5,6,7,8,8a-hexahydronaphthalen-1(4H)-one substituted by hydroxy groups at positions 2, 5 and 8, a (2Z)-3-hydroxyprop-2-enoyl group at position 4, methyl groups at positions 4 and 7 and a 2R-octan-2-yl group at position 3 (the 4S,4aR,5S,7R,8R,8aS stereoisomer). It is isolated from the fermentation extracts of Sporormiella australis and exhibits antifungal activity by interfering with the fungal lipid metabolism.
(rel-5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-16-methoxy-13(14)-labden-15,16-olide|viteagnusin H
2-(2-acetoxytridecyl)-6-hydroxy-4-methoxybenzoic acid
12-Deoxy,2-Ac,4-Me ether-(2R,12S)-6-(2,12-Dihydroxytridecyl)-2,4-dihydroxybenzoic acid
methyl 6beta-hydroxy-18-acetoxy-grindelane methyl ester
dimethyl (14S)-(2E,6E,10Z)-6-methoxycarbonyl-2,10,14-trimethylhexadeca-2,6,10-trienedioate
(2R)-6-(2-acetoxytridecyl)-5-formyl-2-methoxy-1,4-dihydroxybenzene
(rel 5S,6R,8R,9R,10S,13S)-6-acetoxy-9,13-epoxy-15-methoxy-labdan-16,15-olide
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide|(rel 5S,6R,8R,9R,10S)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-olide
C23H36O6_1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,8S,8aR)
(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[(1S,2S,8S,8aR)-2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid_major
(3R,5R)-3,5-Dihydroxy-7-{(1S,2S,8S,8aR)-2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydro-1-naphthalenyl}heptanoic acid
3,5-Dihydroxy-7-[2-methyl-8-(2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid
TG(20:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
methyl (1r,2s,5e)-2-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-5-methyl-9-methylidenecyclonon-5-ene-1-carboxylate
(1e,5e)-1-[6-(2,3-dihydroxy-3-methylbutyl)-3-hydroxy-2-(hydroxymethyl)phenyl]undeca-1,5-diene-3,4-diol
3-[(2e)-7,11-dihydroxy-3,7,11-trimethyldodec-2-en-1-yl]-2,4-dihydroxy-6-methylbenzoic acid
5''-methoxy-2,5,5,8a-tetramethyl-3-oxo-tetrahydro-4h-dispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate
4-hydroxy-4-[2-(2-methoxy-5-oxo-2h-furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
methyl 2-[(1r,3s,4e,7e,11s,12r)-11-(acetyloxy)-3,12-dihydroxy-4,8,12-trimethylcyclotetradeca-4,7-dien-1-yl]prop-2-enoate
asebotoxin ii
{"Ingredient_id": "HBIN017047","Ingredient_name": "asebotoxin ii","Alias": "NA","Ingredient_formula": "C23H36O6","Ingredient_Smile": "CCC(=O)OC1C2CCC3C1(CC(C4(C(C3=C)CC(C4(C)C)O)O)O)CC2(C)O","Ingredient_weight": "408.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135876151","DrugBank_id": "NA"}